TCRT Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2024Q2

0.00

-100%

Estimates Revision

Stock Price

Go Down

-9.48%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Alaunos Therapeutics Inc (TCRT.O) is -0.08, compared to its 5-year average forward P/E of -3.53. For a more detailed relative valuation and DCF analysis to assess Alaunos Therapeutics Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-3.53

Current PE

-0.08

Overvalued PE

-0.68

Undervalued PE

-6.38

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-0.45

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

1.62

Undervalued EV/EBITDA

-2.52

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

3422.46

Current PS

0.00

Overvalued PS

13160.04

Undervalued PS

-6315.13

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

TCRT News & Events

Events Timeline

No data

News

2.0

2025-09-03Benzinga

4 Biotech Stocks Experiencing Decline: Momentum Scores Diminishing in the Last Week

8.5

2025-06-18Globenewswire

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

8.5

2025-05-14Newsfilter

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)

People Also Watch

Frequently Asked Questions

What is Alaunos Therapeutics Inc (TCRT) stock price today?

The current price of TCRT is 3.15 USD — it has decreased -11.02 % in the last trading day.

What is Alaunos Therapeutics Inc (TCRT)'s business?

Alaunos Therapeutics, Inc. is a pre-clinical obesity and metabolic disorder and clinical-stage oncology-focused cell therapy company. The Company focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The Company is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The Company has not generated any revenues.

What is the price predicton of TCRT Stock?

Wall Street analysts forecast TCRT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for TCRT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Alaunos Therapeutics Inc (TCRT)'s revenue for the last quarter?

Alaunos Therapeutics Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

What is Alaunos Therapeutics Inc (TCRT)'s earnings per share (EPS) for the last quarter?

Alaunos Therapeutics Inc. EPS for the last quarter amounts to -0.53 USD, decreased -24.29 % YoY.

What changes have occurred in the market's expectations for Alaunos Therapeutics Inc (TCRT)'s fundamentals?

The market is revising No Change the revenue expectations for TCRT for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -9.48%.

How many employees does Alaunos Therapeutics Inc (TCRT). have?

Alaunos Therapeutics Inc (TCRT) has 1 emplpoyees as of January 10 2026.

What is Alaunos Therapeutics Inc (TCRT) market cap?

Today TCRT has the market capitalization of 7.03M USD.